Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
HTWR: Stock Quote & Summary Data
0.06%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 27,283 |
| Previous Close | $ 32.66 |
| 52 Wk High / Low | $ 35.75 / $ 18.40 |
| Shares Outstanding | 11,713,000 |
| Market Value | $ 382,312,320 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.41 |
| NASDAQ Official Open Price: | $ 33.02 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 32.64 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About HTWR?
Ask your question about about Heartware International, Inc. (HTWR) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
HeartWare is a medical device company focused on developing small implantable pumps for the treatment of advanced heart failure. Our first product, the HeartWare Ventricular Assist System (the “HeartWare System”), which includes a left ventricular assist device (“LVAD”), related accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. The core of the HeartWare System is a proprietary continuous flow blood pump, the HVAD Pump, a full-output device capable of pumping up to 10 liters of blood per minute. The HeartWare System has received Conformite Europeene (“CE”) Marking in January 2009 which allows for commercial sales in Europe and is the subject of an ongoing US bridge-to-transplant clinical trial under an Investigational Device Exemption (“IDE”) granted by the United States Food and Drug Administration (“FDA”). ... More ...
Links to all Heartware International, Inc. (HTWR) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for HTWR |
||
|
HeartWare to Present at Upcoming Investment Conferences in November - PR Newswire 11/06/2009 6:00AM |
||
|
HeartWare International Q3 09 Earnings Conference Call At 8:00 AM - RTT News 11/05/2009 7:04AM |
||
|
HeartWare Q3 Loss Widens - Quick Facts - RTT News 11/04/2009 6:32PM |
||
|
HeartWare International Reports Third Quarter Revenues of $7.5 Million - PR Newswire 11/04/2009 6:00PM |
||
|
HeartWare to Report 2009 Third Quarter and Nine Month Financial Results - GlobeNewswire 10/28/2009 6:05PM |
||
|
HeartWare International Granted FDA Approval To Expand To 40 Clinical Sites For Its U.S. Bridge-to-Transplant Clinical Trial - Quick Facts - RTT News 10/05/2009 4:06PM |
||
|
U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial - PR Newswire 10/05/2009 4:00PM |
